KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Treasury Shares: 2024-2025

Historic Treasury Shares for Xenon Pharmaceuticals (XENE) over the last 2 years, with Sep 2025 value amounting to $313,382.

  • Xenon Pharmaceuticals' Treasury Shares rose 49.23% to $313,382 in Q3 2025 from the same period last year, while for Sep 2025 it was $313,382, marking a year-over-year increase of 49.23%. This contributed to the annual value of $210,000 for FY2024, which is N/A change from last year.
  • Xenon Pharmaceuticals' Treasury Shares amounted to $313,382 in Q3 2025, which was down 1.13% from $316,957 recorded in Q2 2025.
  • In the past 5 years, Xenon Pharmaceuticals' Treasury Shares ranged from a high of $316,957 in Q2 2025 and a low of $192,000 during Q1 2024.
  • For the 2-year period, Xenon Pharmaceuticals' Treasury Shares averaged around $245,698, with its median value being $210,000 (2024).
  • Data for Xenon Pharmaceuticals' Treasury Shares shows a peak YoY surged of 62.54% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Xenon Pharmaceuticals' Treasury Shares stood at $210,000 in 2024, then soared by 49.23% to $313,382 in 2025.
  • Its Treasury Shares was $313,382 in Q3 2025, compared to $316,957 in Q2 2025 and $282,550 in Q1 2025.